Thyrotropin acts as a T-cell developmental factor in mice and humans

Thyroid

Volumn 24, Issue 6, 2014, Pages 1051-1061

  Van Der Weerd, Kim ^a,c   Van Hagen, P Martin ^a   Schrijver, Benjamin ^a   Heuvelmans, Sjanneke J W M ^a   Hofland, Leo J ^a   Swagemakers, Sigrid M A ^a,b   Bogers, Ad J J C ^a   Dik, Willem A ^a   Visser, Theo J ^a   Van Dongen, Jacques J M ^a   Van Der Lelij, Aart Jan ^a   Staal, Frank J T ^a,c  

^a Department of Immunology ^*  (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYCLIC AMP; RECOMBINANT THYROTROPIN; RNA; THYROTROPIN RECEPTOR; SIGNAL PEPTIDE; THYROTROPIN;

ANIMAL CELL; ARTICLE; CHILD; COCULTURE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GRAVES DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFANT; LYMPHOCYTE DIFFERENTIATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE; THYMOCYTE; THYMUS; THYMUS HYPERPLASIA; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; METABOLISM; NEWBORN; PHYSIOLOGY; PRESCHOOL CHILD; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CHILD; CHILD, PRESCHOOL; COCULTURE TECHNIQUES; HUMANS; INFANT; INFANT, NEWBORN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE, INBRED BALB C; RECEPTORS, THYROTROPIN; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND; THYROTROPIN;

EID: 84902129748     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0396     Document Type: Article

References (59)

1. 1. Rothenberg EV, Moore JE, Yui MA 2008 Launching the Tcell-lineage developmental programme. Nat Rev Immunol 8:9-21.
2. Ciofani M, Zuniga-Pflucker JC 2007 The thymus as an inductive site for T lymphopoiesis. Annu Rev Cell Dev Biol 23:463-493.
3. Anderson G, Jenkinson WE, Jones T, Parnell SM, Kinsella FA, White AJ, Pongraćz JE, Rossi SW, Jenkinson EJ 2006 Establishment and functioning of intrathymic microenvironments. Immunol Rev 209:10-27.
4. Taghon T, Rothenberg EV 2008 Molecular mechanisms that control mouse and human TCR-alphabeta and TCRgammadelta T cell development. Semin Immunopathol 30: 383-398.
5. Dik WA, Pike-Overzet K, Weerkamp F, de Ridder D, de Haas EF, Baert MR, van der Spek P, Koster EE, Reinders MJ, van Dongen JJ, Langerak AW, Staal FJ 2005 New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med 201:1715-1723. (Pubitemid 41002890)
6. Kelley KW, Weigent DA, Kooijman R 2007 Protein hormones and immunity. Brain Behav Immun 21:384-392. (Pubitemid 46553732)
7. Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N, Zujewski J, Cowan K, Gress RE 1997 Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90:3789-3798. (Pubitemid 27473453)
8. McCune JM 2001 The dynamics of CD4 + T-cell depletion in HIV disease. Nature 410:974-979. (Pubitemid 32335848)
9. Douek DC, Vescio RA, Betts MR, Brenchley JM, Hill BJ, Zhang L, Berenson JR, Collins RH, Koup RA 2000 Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 355:1875-1881. (Pubitemid 30311880)
10. Taub DD, Longo DL 2005 Insights into thymic aging and regeneration. Immunol Rev 205:72-93. (Pubitemid 40780178)
11. Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, Cahn JY, Passweg JR, Rowlings PA, SchoutenHC, Kolb HJ,Klein JP 1999 Long-termsurvival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 341:14-21.
12. King C, Ilic A, Koelsch K, Sarvetnick N 2004 Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117:265-277. (Pubitemid 38496245)
13. Williams KM, Hakim FT, Gress RE 2007 T cell immune reconstitution following lymphodepletion. Semin Immunol 19:318-330. (Pubitemid 350181530)
14. Goldberg GL, Zakrzewski JL, Perales MA, van den Brink MR 2007 Clinical strategies to enhance T cell reconstitution. Semin Immunol 19:289-296. (Pubitemid 350181526)
15. Weerkamp F, Pike-Overzet K, Staal FJ 2006 T-sing progenitors to commit. Trends Immunol 27:125-131.
16. Savino W, Dardenne M 2000 Neuroendocrine control of thymus physiology. Endocr Rev 21:412-443. (Pubitemid 32275587)
17. Dutton CM, Joba W, Spitzweg C, Heufelder AE, Bahn RS 1997 Thyrotropin receptor expression in adrenal, kidney, and thymus. Thyroid 7:879-884. (Pubitemid 28041662)
18. Murakami M, Hosoi Y, Negishi T, Kamiya Y, Miyashita K, Yamada M, Iriuchijima T, Yokoo H, Yoshida I, Tsushima Y, Mori M 1996 Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus. J Clin Invest 98:2228-2234. (Pubitemid 26394195)
19. Murakami M, Hosoi Y, Araki O, Morimura T, Imamura M, Ogiwara T, Mizuma H, Mori M 2001 Expression of thyrotropin receptors in rat thymus. Life Sci 68:2781-2787. (Pubitemid 32448884)
20. Bagriacik EU, Klein JR 2000 The thyrotropin (thyroidstimulating hormone) receptor is expressed on murine dendritic cells and on a subset of CD45RBhigh lymph node T cells: Functional role for thyroid-stimulating hormone during immune activation. J Immunol 164:6158-6165. (Pubitemid 30408792)
21. Chabaud O, Lissitzky S 1977 Thyrotropin-specific binding to human peripheral blood monocytes and polymorphonuclear leukocytes. Mol Cell Endocrinol 7:79-87.
22. Wortsman J, McConnachie P, Baker JR Jr, Burman KD 1988 Immunoglobulins that cause thymocyte proliferation from a patient with Graves' disease and an enlarged thymus. Am J Med 85:117-121.
23. Gunn A, Michie W, Irvine WJ 1964 The thymus in thyroid disease. Lancet 2:776-778.
24. Costagliola S, Swillens S, Niccoli P, Dumont JE, Vassart G, Ludgate M 1992 Binding assay for thyrotropin receptor autoantibodies using the recombinant receptor protein. J Clin Endocrinol Metab 75:1540-1544. (Pubitemid 23001419)
25. Taghon T, Van de Walle I, De Smet G, De Smedt M, Leclercq G, Vandekerckhove B, Plum J 2009 Notch signaling is required for proliferation but not for differentiation at a well-defined beta-selection checkpoint during human T-cell development. Blood 113:3254-3263.
26. Schmitt TM, Zuniga-Pflucker JC 2002 Induction of T cell development from hematopoietic progenitor cells by deltalike-1 in vitro. Immunity 17:749-756. (Pubitemid 35477794)
27. Staal FJ, Weerkamp F, Langerak AW, Hendriks RW, Clevers HC 2001 Transcriptional control of T lymphocyte differentiation. Stem Cells 19:165-179. (Pubitemid 32524538)
28. van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, Delabesse E, Davi F, Schuuring E, Garcia-Sanz R, van Krieken JH, Droese J, Gonzalez D, Bastard C, White HE, Spaargaren M, Gonzalez M, Parreira A, Smith JL, Morgan GJ, Kneba M, Macintyre EA 2003 Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257-2317. (Pubitemid 38072572)
29. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, Delabesse E, Macintyre E, Gottardi E, Saglio G, Watzinger F, Lion T, van Dongen JJ, Hokland P, Gabert J 2003 Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-a Europe against cancer program. Leukemia 17:2474-2486. (Pubitemid 38072587)
30. van den Berg HR, Khan NA, van der Zee M, Bonthuis F, JNIJ, Dik WA, de Bruin RW, Benner R 2009 Synthetic oligopeptides related to the [beta]-subunit of human chorionic gonadotropin attenuate inflammation and liver damage after (trauma) hemorrhagic shock and resuscitation. Shock 31:285-291.
31. Visser-Wisselaar HA, Van Uffelen CJ, Van Koetsveld PM, Lichtenauer-Kaligis EG,Waaijers AM, Uitterlinden P, Mooy DM, Lamberts SW, Hofland LJ 1997 17-beta-estradioldependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo. Endocrinology 138:1180-1189. (Pubitemid 27089776)
32. van Zelm MC, Reisli I, van der Burg M, Castano D, van Noesel CJ, van Tol MJ, Woellner C, Grimbacher B, Patino PJ, van Dongen JJ, Franco JL 2006 An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354:1901-1912. (Pubitemid 43872691)
33. Pike-Overzet K, de Ridder D, Weerkamp F, Baert MR, Verstegen MM, Brugman MH, Howe SJ, Reinders MJ, Thrasher AJ, Wagemaker G, van Dongen JJ, Staal FJ 2007 Ectopic retroviral expression of LMO2, but not IL2Rgamma, blocks human T-cell development from CD34 + cells: implications for leukemogenesis in gene therapy. Leukemia 21:754-763. (Pubitemid 46444560)
34. Luis TC, Weerkamp F, Naber BA, Baert MR, de Haas EF, Nikolic T, Heuvelmans S, De Krijger RR, van Dongen JJ, Staal FJ 2009 Wnt3a deficiency irreversibly impairs hematopoietic stem cell self-renewal and leads to defects in progenitor cell differentiation. Blood 113:546-554.
35. Hershman JM 2004 Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab 18: 249-265. (Pubitemid 38801668)
36. Nakabayashi K, Matsumi H, Bhalla A, Bae J, Mosselman S, Hsu SY, Hsueh AJ 2002 Thyrostimulin, a heterodimer of two new human glycoprotein hormone subunits, activates the thyroid-stimulating hormone receptor. J Clin Invest 109:1445-1452. (Pubitemid 34596170)
37. Powell-Jones CH, Thomas CG Jr, Nayfeh SN 1980 Thyrotropin receptors in normal human thyroid. Nonclassical binding kinetics not explained by the negative cooperativity model. J Biol Chem 255:4001-4010. (Pubitemid 10053034)
38. Latif R, Morshed SA, Zaidi M, Davies TF 2009 The thyroid-stimulating hormone receptor: impact of thyroidstimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling. Endocrinol Metab Clin North Am 38:319-341, viii.
39. Stein SA, Oates EL, Hall CR, Grumbles RM, Fernandez LM, Taylor NA, Puett D, Jin S 1994 Identification of a point mutation in the thyrotropin receptor of the hyt/hyt hypothyroid mouse. Mol Endocrinol 8:129-138. (Pubitemid 24067100)
40. de Pooter R, Zuniga-Pflucker JC 2007 T-cell potential and development in vitro: the OP9-DL1 approach. Curr Opin Immunol 19:163-168. (Pubitemid 46356972)
41. Jenkinson EJ, Anderson G 1994 Fetal thymic organ cultures. Curr Opin Immunol 6:293-297. (Pubitemid 24106827)
42. Sorisky A, Antunes TT, Gagnon A 2008 The Adipocyte as a novel TSH target. Mini Rev Med Chem 8:91-96. (Pubitemid 351320933)
43. Zhang W, Tian LM, Han Y, Ma HY, Wang LC, Guo J, Gao L, Zhao JJ 2009 Presence of thyrotropin receptor in hepatocytes: not a case of illegitimate transcription. J Cell Mol Med 13:4636-4642.
44. Abe E, Marians RC, Yu W, Wu XB, Ando T, Li Y, Iqbal J, Eldeiry L, Rajendren G, Blair HC, Davies TF, Zaidi M 2003 TSH is a negative regulator of skeletal remodeling. Cell 115:151-162. (Pubitemid 37329579)
45. Wang J, Whetsell M, Klein JR 1997 Local hormone networks and intestinal T cell homeostasis. Science 275: 1937-1939. (Pubitemid 27148816)
46. Spitzweg C, Joba W, Heufelder AE 1999 Expression of thyroid-related genes in human thymus. Thyroid 9:133-141. (Pubitemid 29115533)
47. Colobran R, Armengol Mdel P, Faner R, Gartner M, Tykocinski LO, Lucas A, Ruiz M, Juan M, Kyewski B, Pujol-Borrell R 2011 Association of an SNP with intrathymic transcription of TSHR and Graves' disease: a role for defective thymic tolerance. Hum Mol Genet 20:3415-3423.
48. Jiang S, Chow SC, Nicotera P, Orrenius S 1994 Intracellular Ca2 + signals activate apoptosis in thymocytes: studies using the Ca(2 + )-ATPase inhibitor thapsigargin. Exp Cell Res 212:84-92.
49. Carleton M, Haks MC, Smeele SA, Jones A, Belkowski SM, Berger MA, Linsley P, Kruisbeek AM, Wiest DL 2002 Early growth response transcription factors are required for development of CD4(-)CD8(-) thymocytes to the CD4( + )CD8( + ) stage. J Immunol 168:1649-1658. (Pubitemid 34135760)
50. Aifantis I, Gounari F, Scorrano L, Borowski C, von Boehmer H 2001 Constitutive pre-TCR signaling promotes differentiation through Ca2 + mobilization and activation of NF-kappaB and NFAT. Nat Immunol 2:403-409. (Pubitemid 33706137)
51. Gupta A, Terhorst C 1994 CD3 delta enhancer. CREB interferes with the function of a murine CD3-delta A binding factor (M delta AF). J Immunol 152:3895-3903. (Pubitemid 24111061)
52. Gottschalk LR, Leiden JM 1990 Identification and functional characterization of the human T-cell receptor beta gene transcriptional enhancer: common nuclear proteins interact with the transcriptional regulatory elements of the T-cell receptor alpha and beta genes. Mol Cell Biol 10: 5486-5495.
53. Grady GC, Mason SM, Stephen J, Zuniga-Pflucker JC, Michie AM 2004 Cyclic adenosine 5¢-monophosphate response element binding protein plays a central role in mediating proliferation and differentiation downstream of the pre-TCR complex in developing thymocytes. J Immunol 173:1802-1810. (Pubitemid 38971613)
54. Wang J, Klein JR 1996 Hormone regulation of murine T cells: potent tissue-specific immunosuppressive effects of thyroxine targeted to gut T cells. Int Immunol 8:231-235. (Pubitemid 26049775)
55. Schmitt TM, Zuniga-Pflucker JC 2005 Thymus-derived signals regulate early T-cell development. Crit Rev Immunol 25:141-159. (Pubitemid 40910586)
56. Overwijk WW, Schluns KS 2009 Functions of cC cytokines in immune homeostasis: current and potential clinical applications. Clin Immunol 132:153-165.
57. Sportes C, Gress RE, Mackall CL 2009 Perspective on potential clinical applications of recombinant human interleukin-7. Ann NY Acad Sci 1182:28-38.
58. Kratzsch J, Pulzer F 2008 Thyroid gland development and defects. Best Pract Res Clin Endocrinol Metab 22:57-75. (Pubitemid 351218277)
59. Ygberg S, Nilsson A 2012 The developing immune system-from foetus to toddler. Acta Paediatr 101:120-127.